The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 118:156-158, August 1961
doi: 10.1176/appi.ajp.118.2.156
© 1961 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by JUDAH, L. N.
* Articles by MURPHREE, O. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by JUDAH, L. N.
* Articles by MURPHREE, O. D.

RESULTS OF SIMULTANEOUS ABRUPT WITHDRAWAL OF ATARAXICS IN 500 CHRONIC PSYCHOTIC PATIENTS

L. N. JUDAH M.D., Z. M. JOSEPHS M.D., , and O. D. MURPHREE PH.D.1

1 VA Consolidated Hosp., N. Little Rock Div., Little Rock, Ark.

It is our opinion that the sudden withdrawal of tranquilizers from chronic psychotics living in a protective and reasonably permissive ward atmosphere will do no apparent harm to their condition in the majority of patients for a period ranging up to 5 months. Withdrawal symptoms were few, mild, and easily controlled, and asocial conduct usually subsided readily when the drugs were readministered. Drug intake as measured by duration, or dosage, or type of drug does not seem to be a factor as to how long a case can remain off medication socially. Neither do diagnosis, or apparent duration of illness, or age, except that those within the geriatric period seemed to remain off medication for the 90-day period in somewhat larger percentage. The results of this experiment seem to confirm a 1954 study(2) by a group at this hospital which found that clinical response and the pattern of resistive isolation in the Lorr Scale were the main improvements to be expected following the use of chlorpromazine and reserpine–and the present authors feel that this may well be true of all tranquilizers on this type of patient.







Get information about faster international access.

Privacy Policy

Copyright © 1961 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org